Clinical Trials on Neuroendocrine Tumor Grade 2 in United States
Total 2880 results
-
Diwakar DavarBristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminated
-
University of PennsylvaniaCompleted
-
Massachusetts General HospitalTerminated
-
Northwestern UniversityCompleted
-
Northwestern UniversityCompletedMelanomaUnited States
-
Massachusetts General HospitalBayer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedMelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); University of TexasCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Pfizer; Oncovir, Inc.Completed
-
University of PittsburghTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedMelanomaUnited States
-
M.D. Anderson Cancer CenterCompletedMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Rockefeller...CompletedMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
National Center for Research Resources (NCRR)Unknown
-
IpsenCompletedNeuroendocrine Tumours (NET)United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Childhood Grade I Meningioma | Childhood Grade II Meningioma | Childhood Grade III Meningioma | Childhood Infratentorial Ependymoma | Childhood Supratentorial Ependymoma | Recurrent Childhood... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingSmall Cell Carcinoma of the Bladder | High Grade Neuroendocrine Tumors of the Urinary TractUnited States
-
ImmVira Pharma Co. LtdRecruitingMelanoma | Sarcoma | NSCLC | Solid Tumor | HNSCC | Squamous Cell CarcinomaUnited States, Australia
-
Robert LowskyNational Cancer Institute (NCI); Janssen, LP; The Leukemia and Lymphoma Society; Rising Tide FoundationCompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
University of California, San FranciscoBeiGene USA, Inc.; Pacific Pediatric Neuro-Oncology ConsortiumRecruitingGlioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent WHO Grade III Glioma | WHO Grade III Glioma | IDH2 Gene Mutation | IDH1 Gene Mutation | Low Grade Glioma | Recurrent WHO Grade II Glioma | WHO Grade II GliomaUnited States
-
Wolfram SamlowskiUniversity of Pittsburgh; Comprehensive Cancer Centers of Nevada; TrueCells, LLCCompleted
-
University of California, DavisRecruiting
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology... and other collaboratorsSuspended
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Prometheus Laboratories; Key Biologics, LLC; Adelson...Active, not recruiting
-
Mayo ClinicActive, not recruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Active, not recruiting
-
University of VirginiaCompletedMelanomaUnited States
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Terminated
-
John KirkwoodBristol-Myers SquibbActive, not recruiting
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Genentech, Inc.CompletedMelanomaUnited States
-
University of PennsylvaniaActive, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Celgene CorporationCompleted
-
M.D. Anderson Cancer CenterTerminated
-
Dana-Farber Cancer InstituteEli Lilly and CompanyActive, not recruiting
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Northwestern UniversitySarah M. Friedewald, MD; Jennifer N. Choi, MDCompleted
-
Loyola UniversityNational Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)Completed
-
Philip FriedlanderGenentech, Inc.TerminatedMelanomaUnited States
-
M.D. Anderson Cancer CenterSchering-PloughCompletedMelanomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNovartis; National Comprehensive Cancer NetworkCompleted
-
NYU Langone HealthTerminated
-
Mayo ClinicCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKline; Oncovir, Inc.Terminated